NEW YORK (GenomeWeb News) – Affymetrix will shutter its instrument manufacturing and development facility in Bedford, Mass., this winter as part of a broader plan to cut costs, according to a filing with Securities and Exchange Commission yesterday.
 
The move, which Affy “committed to” on Sept. 7, will consolidate the facility's instrument manufacturing operations with the company's probe array-manufacturing space in West Sacramento, Calif.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.